Package 27241-298-30

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 27241-298-30
Digits Only 2724129830
Product NDC 27241-298
Description

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-298-30)

Marketing

Marketing Status
Marketed Since 2025-09-02
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "29c8e48a-014b-428c-83dd-6b18a14a8fec", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0327241297304", "0327241296307", "0327241299308", "0327241300301", "0327241298301"], "unii": ["0H73WJJ391"], "rxcui": ["1494769", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["813f5fe2-df82-479c-8014-d503ff5df52b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-298-30)", "package_ndc": "27241-298-30", "marketing_start_date": "20250902"}], "brand_name": "Topiramate", "product_id": "27241-298_29c8e48a-014b-428c-83dd-6b18a14a8fec", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "27241-298", "generic_name": "Topiramate", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA219564", "marketing_category": "ANDA", "marketing_start_date": "20250902", "listing_expiration_date": "20261231"}